Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Autor: Lucy Smyth, Andrea Mazzetti, Charles D. Pusey, Lorraine Harper, Donna Reidlinger, Gina Gregorini, William F. Clark, Pexivas Investigators Pexivas Investigators, Adeera Levin, Toshiko Ito-Ihara, Chen-Au Peh, Xavier Puéchal, Ulrich Specks, Carmel M. Hawley, Oliver Floßmann, Simon Carette, Alina Casian, Wojciech Szczeklik, Peter A. Merkel, Janak de Zoysa, Nader Khalidi, David Jayne, Samir Mehta, Biljana Brezina, Ron Wald, Michael Walsh, Luis Felipe Flores-Suárez, Carol A. McAlear, L. Guillevin, Louis Girard, Natalie Ives, Wladimir Szpirt, Vladimir Tesar, Elizabeth Broadhurst, Christian Pagnoux, Shouichi Fujimoto
Přispěvatelé: McMaster University [Hamilton, Ontario], Royal Adelaide Hospital [Adelaide Australia], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Miyazaki, McMaster University, St. Joseph’s Healthcare, Royal Berkshire Hospital, St. Michael's Hospital, University of British Columbia (UBC), Università degli Studi di Brescia [Brescia], Mount Sinai Hospital [Toronto, Canada] (MSH), Mayo Clinic [Rochester], Charles University [Prague] (CU), Instituto Nacional de Enfermedades Respiratorias [México, Mexico], University of Cambridge [UK] (CAM), Addenbrooke's Hospital, Cambridge University NHS Trust
Rok vydání: 2020
Předmět:
MESH: Combined Modality Therapy
medicine.medical_specialty
Cyclophosphamide
medicine.medical_treatment
Azathioprine
030204 cardiovascular system & hematology
urologic and male genital diseases
[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
Gastroenterology
MESH: Dose-Response Relationship
Drug

MESH: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03 medical and health sciences
0302 clinical medicine
Maintenance therapy
immune system diseases
Internal medicine
Medicine
MESH: Incidence
cardiovascular diseases
030212 general & internal medicine
skin and connective tissue diseases
Anti-neutrophil cytoplasmic antibody
MESH: Aged
MESH: Kidney Diseases
MESH: Middle Aged
MESH: Humans
business.industry
MESH: Cyclophosphamide
MESH: Adult
Glomerulonephritis
General Medicine
MESH: Plasma Exchange
medicine.disease
MESH: Induction Chemotherapy
MESH: Male
respiratory tract diseases
3. Good health
MESH: Kidney Failure
Chronic

MESH: Administration
Oral

Rituximab
Plasmapheresis
MESH: Immunosuppressive Agents
MESH: Rituximab
MESH: Glucocorticoids
business
Vasculitis
MESH: Female
medicine.drug
Zdroj: Walsh, M, Merkel, P A, Peh, C, Szpirt, W M, Puéchal, X, Fujimoto, S, Hawley, C M, Khalidi, N, Floßmann, O, Wald, R, Girard, L P, Levin, A, Gregorini, G, Harper, L, Clark, W F, Pagnoux, C, Specks, U, Smyth, L, Tesar, V, Ito-ihara, T, De Zoysa, J R, Szczeklik, W, Flores-suárez, L F, Carette, S, Guillevin, L, Pusey, C D, Casian, A L, Brezina, B, Mazzetti, A, Mcalear, C A, Broadhurst, E, Reidlinger, D, Mehta, S, Ives, N & Jayne, D R W 2020, ' Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis ', New England Journal of Medicine, vol. 382, no. 7, pp. 622-631 . https://doi.org/10.1056/NEJMoa1803537
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2020, 382 (7), pp.622-631. ⟨10.1056/NEJMoa1803537⟩
ISSN: 1533-4406
0028-4793
DOI: 10.1056/nejmoa1803537
Popis: BACKGROUND More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. METHODS We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two regimens of oral glucocorticoids in patients with severe ANCA-associated vasculitis (defined by an estimated glomerular filtration rate of
Databáze: OpenAIRE